Scarica l'app Stockscreener
245.74
0.87%
2.13
Dopo l'orario di chiusura:
245.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$243.61
Aprire:
$243.61
Volume 24 ore:
1.07M
Relative Volume:
1.10
Capitalizzazione di mercato:
$36.10B
Reddito:
$4.81B
Utile/perdita netta:
$1.11B
Rapporto P/E:
39.89
EPS:
6.16
Flusso di cassa netto:
$1.35B
1 W Prestazione:
+0.55%
1M Prestazione:
+5.03%
6M Prestazione:
+13.25%
1 anno Prestazione:
+60.81%
Intervallo 1D:
$241.28
$246.51
Intervallo di 1 settimana:
$240.53
$247.75
Portata 52W:
$140.81
$260.49
Resmed Inc Stock (RMD) Company Profile
Nome
Resmed Inc
Settore
Industria
Telefono
(858) 746-2400
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-05 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | Iniziato | UBS | Buy |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-01-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-09-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-08-15 | Downgrade | CLSA | Buy → Outperform |
| 2022-08-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-01-28 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-01-13 | Aggiornamento | CLSA | Outperform → Buy |
| 2022-01-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-10-22 | Aggiornamento | CLSA | Underperform → Outperform |
| 2021-08-02 | Downgrade | CLSA | Outperform → Sell |
| 2021-08-02 | Downgrade | Needham | Buy → Hold |
| 2021-07-28 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-14 | Iniziato | RBC Capital Mkts | Underperform |
| 2021-06-28 | Downgrade | Citigroup | Buy → Neutral |
| 2021-06-22 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-06-22 | Iniziato | Robert W. Baird | Neutral |
| 2021-06-21 | Reiterato | Needham | Buy |
| 2021-06-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-09 | Aggiornamento | CLSA | Sell → Outperform |
| 2021-05-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-30 | Downgrade | Citigroup | Buy → Neutral |
| 2021-03-16 | Aggiornamento | Needham | Hold → Buy |
| 2020-11-02 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-10-27 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-01 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Iniziato | CLSA | Underperform |
| 2020-01-31 | Downgrade | UBS | Buy → Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Perform |
| 2019-11-22 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | Aggiornamento | UBS | Neutral → Buy |
| 2019-07-16 | Downgrade | UBS | Buy → Neutral |
| 2019-05-06 | Aggiornamento | UBS | Neutral → Buy |
| 2019-04-18 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-01-25 | Downgrade | Goldman | Buy → Neutral |
| 2019-01-25 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | Iniziato | Goldman | Buy |
Mostra tutto
Resmed Inc Borsa (RMD) Ultime notizie
ResMed Announces Participation in the UBS Global Healthcare Conference - GlobeNewswire
Up 45% in 2024! Can ResMed shares keep rising? - The Motley Fool Australia
ResMed Inc. (NYSE:RMD) General Counsel Sells $16,698.00 in Stock - MarketBeat
Ex-Dividend Reminder: Ford Motor, FirstEnergy and ResMed - Nasdaq
Pittenger & Anderson Inc. Acquires 5,034 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc Reports CDI and Stock Adjustments - MSN
ResMed Executive Transfers Shares to Family Trust - MSN
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance Australia
Air Voel’s Commitment to Sleep Health: Innovative CPAP Machines for Comfortable and Restorative Sleep - The Globe and Mail
Capital Investment Services of America Inc. Lowers Stock Position in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. Corrects Proxy Statement Details - MSN
ResMed Inc. (NYSE:RMD) Looks Interesting, And It's About To Pay A Dividend - Simply Wall St
Should You Buy ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend? - Yahoo Finance
Stephens Inc. AR Acquires 11,638 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. stock rises Friday, outperforms market - MarketWatch
We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease - Simply Wall St
Stephens Investment Management Group LLC Increases Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Want the latest ResMed dividend? Here's what you need to do - MSN
ResMed Inc. stock outperforms market despite losses on the day - MarketWatch
ResMed Inc. (NYSE:RMD) Shares Sold by Congress Asset Management Co. - MarketBeat
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
ResMed Quarterly Revenue Up 11% Due to CPAP and Mask Demand - Sleep Review
ResMed Inc. Reports Compliance and Stock Details - MSN
abrdn plc Purchases 33,451 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Why Domino's, Encounter, Magnetic Resources, and ResMed shares are rising today - MSN
Best Travel CPAP Machines in 2024: A Complete Guide - National Council on Aging
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation - GlobeNewswire
ResMed Inc. (NYSE:RMD) Holdings Lifted by Smith Group Asset Management LLC - MarketBeat
ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Call Transcript - MSN
Best CPAP Masks of 2024: Reviewed by Experts - National Council on Aging
Why this fundie is backing ResMed shares in FY25 - MSN
ResMed (NYSE:RMD) Stock Price Down 2.8%Should You Sell? - MarketBeat
P/E Ratio Insights for ResMed - Benzinga
Why Investors Are Eyeing ResMed Inc (RMD): The Key Drivers of Ma - GuruFocus.com
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance Australia
Analyst recommendations: Aon, Ciena, Nutanix, Reddit, Resmed... - Marketscreener.com
Semanteon Capital Management LP Acquires 2,854 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Why DroneShield, Newmont, ResMed, and Vulcan Energy shares are storming higher - MSN
Morgans rates RMD as Add - Marketscreener.com
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-bust ... - Stockhead
ResMed Inc. (NYSE:RMD) Shares Acquired by Valley National Advisers Inc. - MarketBeat
ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand - MSN
ResMed First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Decoding ResMed Inc (RMD): A Strategic SWOT Insight - GuruFocus.com
ResMed’s revenue jumps 11% to USD 1.2 billion in Q1 2025 - Medical Buyer
ResMed Inc. (NYSE:RMD) Shares Sold by Cullinan Associates Inc. - MarketBeat
ResMed stock soars to 52-week high, hits $259.67 By Investing.com - Investing.com Canada
Brokerages Set ResMed Inc. (NYSE:RMD) Target Price at $220.55 - MarketBeat
Resmed Inc Azioni (RMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
5.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):